Tuberculosis Diagnosis
Ziehl-Neelsen-stained slides enable resistance testing without culture
Published in TB and Outbreaks Week, May 6th, 2003
"Multidrug resistance among new cases of tuberculosis (TB) is increasingly becoming a significant problem in countries with a high prevalence of TB and with inadequate therapies for TB," researchers in the Netherlands explained. "Rifampin resistance is widely used as a marker for multidrug-resistant (MDR) TB; therefore, a new approach to the retrospective measurement of rifampin resistance without the need of a viable culture has been introduced."
"In many developing countries culture is unavailable and diagnosis relies on clinical manifestations and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Tuberculosis Diagnosis
Abnormal radiological presentation more likely in diabetics - Tuberculosis Therapy
DNA polymerase gene linked to drug resistance - Infectious Disease
N. meningitidis serogroup W135 prevalent near Mecca - Infectious Disease Diagnosis
Salivary IgM can be used to detect dengue virus infection - Tuberculosis Diagnosis
Novel genotype assay effective for drug resistance testing - Amebiasis
Peptone-yeast extract medium preferred in definitive diagnosis of amebiasis - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
